CBOA
LLY icon

Commonwealth Bank of Australia’s Eli Lilly LLY Stock Holding History

Commonwealth Bank of Australia’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-61,645
Closed -$6.82M – 541
2019
Q2 		$6.82M Sell
61,645
-6,394
-9% -$753K 0.07% 187
2019
Q1 		$8.82M Sell
68,039
-4,100
-6% -$499K 0.08% 157
2018
Q4 		$8.34M Sell
72,139
-122
-0.2% -$13.6K 0.09% 146
2018
Q3 		$7.75M Buy
72,261
+4,300
+6% +$430K 0.07% 174
2018
Q2 		$5.79M Buy
67,961
+704
+1% +$57.8K 0.06% 198
2018
Q1 		$5.2M Sell
67,257
-10,612
-14% -$854K 0.06% 207
2017
Q4 		$6.57M Buy
77,869
+22,382
+40% +$1.9M 0.06% 202
2017
Q3 		$4.74M Buy
55,487
+19,456
+54% +$1.6M 0.05% 236
2017
Q2 		$2.96M Buy
36,031
+19,887
+123% +$1.62M 0.03% 302
2017
Q1 		$1.36M Buy
16,144
+14,108
+693% +$1.13M 0.01% 435
2016
Q4 		$150K Sell
2,036
-245
-11% -$18.2K ﹤0.01% 600
2016
Q3 		$183K Hold
2,281
– – ﹤0.01% 586
2016
Q2 		$179K Sell
2,281
-41
-2% -$3.09K ﹤0.01% 588
2016
Q1 		$167K Sell
2,322
-43,520
-95% -$3.29M ﹤0.01% 609
2015
Q4 		$3.86M Sell
45,842
-47,123
-51% -$3.91M 0.05% 207
2015
Q3 		$7.78M Buy
92,965
+743
+0.8% +$62.7K 0.1% 136
2015
Q2 		$7.7M Sell
92,222
-3,565
-4% -$272K 0.1% 129
2015
Q1 		$6.96M Sell
95,787
-2,700
-3% -$192K 0.09% 140
2014
Q4 		$6.79M Sell
98,487
-19,424
-16% -$1.31M 0.1% 133
2014
Q3 		$7.65M Buy
117,911
+1,300
+1% +$82.3K 0.1% 140
2014
Q2 		$7.25M Sell
116,611
-368,517
-76% -$22M 0.1% 140
2014
Q1 		$28.6M Buy
485,128
+174,940
+56% +$9.76M 0.18% 129
2013
Q4 		$15.8M Buy
310,188
+28,420
+10% +$1.42M 0.11% 189
2013
Q3 		$14.2M Sell
281,768
-157,071
-36% -$8.22M 0.1% 196
2013
Q2 		$21.6M Buy
+438,839
New +$23.9M 0.16% 137

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Commonwealth Bank of Australia's LLY Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Eli Lilly (LLY) in Q3 2019, closing a stake of 61,645 shares — an estimated $6.82M sold.

Commonwealth Bank of Australia first reported a position in LLY in Q2 2013 and held it in 25 quarters. The position peaked at $28.6M in Q1 2014. 1,525 funds tracked by Wall St. Rank hold LLY as of Q3 2019.

  • Commonwealth Bank of Australia reported no remaining Eli Lilly position as of Q3 2019 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 61,645 Eli Lilly shares in Q3 2019, an estimated $6.82M.
  • Commonwealth Bank of Australia first reported a position in Eli Lilly in Q2 2013 and held it in 25 quarters.
  • Commonwealth Bank of Australia's Eli Lilly position peaked at $28.6M in Q1 2014.
  • 1,525 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.